Needle-free vaccine delivery (Q36945838)

17 August 2017

1 reference

title

Needle-free vaccine delivery (English)

1 reference

17 August 2017

1 reference

1

Gideon Kersten

1 reference

17 August 2017

Hoang Hirschberg

2

1 reference

PubMed ID

17880271

17 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

Expert Opinion on Drug Delivery

17 August 2017

1 reference

17 August 2017

4

1 reference

17 August 2017

5

1 reference

17 August 2017

459-474

1 reference

The MMR vaccination and autism controversy in United Kingdom 1998-2005: inevitable community outrage or a failure of risk communication?

17 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Perspectives on polio and immunization in Northern Nigeria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Needle-free vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Vaccine delivery--current trends and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Novel approaches to pediatric vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Immunization without needles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Needle-free liquid jet injections: mechanisms and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Lipid vesicles and other colloids as drug carriers on the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Transfersomes for transdermal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Topical DNA vaccination with DNA/Lipid based complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Delivering vaccines into the skin without needles and syringes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Microneedles for transdermal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Mucosal delivery of vaccine antigens and its advantages in pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Mucosal immunity and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Delivery systems and adjuvants for oral vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Pulmonary vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Mucosal vaccines: the promise and the challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

The role of adjuvants in the development of mucosal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Preventing needlestick injuries among healthcare workers: a WHO-ICN collaboration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Intranasal Influenza Vaccine in a Working Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

The use of breast-feeding for pain relief during neonatal immunization injections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Use of an oral diphtheria vaccine in human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Candidate live, attenuated Salmonella enterica serotype Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Biosafety evaluation of recombinant live oral bacterial vaccines in the context of European regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Intussusception among infants given an oral rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Rotarix (RIX4414): an oral human rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

The advantage of mucosal immunization for polysaccharide-specific memory responses in early life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

The Mycoplasma-derived macrophage-activating 2-kilodalton lipopeptide triggers global immune activation on nasal mucosa-associated lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

The HIV-1 matrix protein p17 can be efficiently delivered by intranasal route in mice using the TLR 2/6 agonist MALP-2 as mucosal adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Immunisation schedules for non-replicating nasal vaccines can be made simple by allowing time for development of immunological memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Live attenuated versus inactivated influenza vaccine in infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Clinical immunogenicity and tolerance studies of liquid vaccines delivered by jet-injector and a new single-use cartridge (Imule): comparison with standard syringe injection. Imule Investigators Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Epidermal powder immunization against influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Needle-free epidermal powder immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Hepatitis-B surface antigen (HBsAg) powder formulation: process and stability assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Optimization of a jet-propelled particle injection system for the uniform transdermal delivery of drug/vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Antibody responses after dose-sparing intradermal influenza vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Transdermal protein delivery by a coadministered peptide identified via phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Coated microneedles for transdermal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

In vitro and in vivo characterization of MEMS microneedles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Live attenuated oral cholera vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Vaginal protection and immunity after oral immunization of mice with a novel vaccine strain of Listeria monocytogenes expressing human immunodeficiency virus type 1 gag.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Immunogenicity in humans of an edible vaccine for hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Active induction of tumor-specific IgE antibodies by oral mimotope vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Mucosal adjuvant properties of the Shigella invasin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Alternative routes of measles immunization: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Microneedles coated with porous calcium phosphate ceramics: effective vehicles for transdermal delivery of solid trehalose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Low-frequency ultrasound as a transcutaneous immunization adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Needle-free, non-adjuvanted skin immunization by electroporation-enhanced transdermal delivery of diphtheria toxoid and a candidate peptide vaccine against hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Alternative routes of influenza vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Crude saponins improve the immune response to an oral plant-made measles vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.459

21 January 2018

Identifiers

DOI

10.1517/17425247.4.5.459

1 reference

17 August 2017

1 reference

PubMed ID

17880271